Volume 11, Number 1—January 2005
Research
Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001
Edward A. Belongia*
, Burney Kieke*, Ruth Lynfield†, Jeffrey P. Davis‡, and Richard E. Besser§
, Burney Kieke*, Ruth Lynfield†, Jeffrey P. Davis‡, and Richard E. Besser§
Table
Characteristics of Minnesota and Wisconsin clinicians who received requests for antimicrobial agents to prevent anthrax during the last quarter of 2001
| Received requests (%) | p value | |
|---|---|---|
| Prescriber type | ||
| Physician | 52/157 (33) | <0.001 |
| Nonphysician | 6/52 (12) | |
| Practice location | ||
| Metropolitan area | 22/82 (27) | 0.82 |
| Nonmetropolitan area | 36/128 (28) | |
| State | ||
| Minnesota | 29/105 (28) | 1.0 |
| Wisconsin | 29/105 (28) | |
| Physician specialty* | ||
| Family practice | 26/62 (41) | 0.61 |
| Internal medicine | 14/42 (30) | |
| Pediatrics | 8/28 (28) | |
| Emergency medicine | 2/5 (33) |
*Nine physicians who listed 2 specialties and 2 who listed “other” as a specialty were excluded from the frequency distribution for physician specialty.
Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.